Molecular determinants that regulate plasma membrane association of HIV-1 Gag

Journal of Molecular Biology

Volumn 410, Issue 4, 2011, Pages 512-524

  Chukkapalli, Vineela ^a   Ono, Akira ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Assembly; Gag; Matrix; PI(4,5)P2; Plasma membrane

Indexed keywords

GAG PROTEIN; MYRISTIC ACID; PHOSPHATE; VIRUS RNA;

CELL MEMBRANE; EXTRACELLULAR MATRIX; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051718223     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.04.015     Document Type: Review

References (120)

1. Adamson, C. S. & Jones, I. M. (2004). The molecular basis of HIV capsid assembly-five years of progress. Rev. Med. Virol. 14, 107-121. (Pubitemid 38316010)
2. Adamson, C. S. & Freed, E. O. (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv. Pharmacol. 55, 347-387.
3. Gelderblom, H. R., Hausmann, E. H., Ozel, M., Pauli, G. & Koch, M. A. (1987). Fine structure of human immunodeficiency virus (HIV) and immunolocaliza-tion of structural proteins. Virology, 156, 171-176. (Pubitemid 17013661)
4. Deneka, M., Pelchen-Matthews, A., Byland, R., Ruiz-Mateos, E. & Marsh, M. (2007). In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177, 329-341. (Pubitemid 46658643)
5. Welsch, S., Keppler, O. T., Habermann, A., Allespach, I., Krijnse-Locker, J. & Krausslich, H. G. (2007). HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36.
6. Bennett, A. E., Narayan, K., Shi, D., Hartnell, L. M., Gousset, K., He, H. et al. (2009). Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macro-phages. PLoS Pathog. 5, e1000591.
7. Jouvenet, N., Neil, S. J., Bess, C., Johnson, M. C., Virgen, C. A., Simon, S. M. & Bieniasz, P. D. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4, e435.
8. Chu, H., Wang, J. J. & Spearman, P. (2009). Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. Curr. Top. Microbiol. Immunol. 339, 67-84.
9. Ono, A. (2009). HIV-1 assembly at the plasma membrane: gag trafficking and localization. Future Virol. 4, 241-257.
10. Zhou, W., Parent, L. J., Wills, J. W. & Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569.
11. Yuan, X., Yu, X., Lee, T. H. & Essex, M. (1993). Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67, 6387-6394. (Pubitemid 23309102)
12. Ono, A., Orenstein, J. M. & Freed, E. O. (2000). Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74, 2855-2866. (Pubitemid 30117597)
13. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K. & Freed, E. O. (2004). Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA, 101, 14889-14894. (Pubitemid 39410770)
14. Joshi, A., Ablan, S. D., Soheilian, F., Nagashima, K. & Freed, E. O. (2009). Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment. J. Virol. 83, 5375-5387.
15. Massiah, M. A., Starich, M. R., Paschall, C., Summers, M. F., Christensen, A. M. & Sundquist, W. I. (1994). Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244, 198-223. (Pubitemid 24366038)
16. Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M. & Sundquist, W. I. (1996). Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA, 93, 3099-3104. (Pubitemid 26114370)
17. Bryant, M. & Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad. Sci. USA, 87, 523-527.
18. Gottlinger, H. G., Sodroski, J. G. & Haseltine, W. A. (1989). Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 86, 5781-5785. (Pubitemid 19217537)
19. Hermida-Matsumoto, L. & Resh, M. D. (2000). Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74, 8670-8679. (Pubitemid 30666717)
20. Ono, A. & Freed, E. O. (2004). Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multi-vesicular body. J. Virol. 78, 1552-1563. (Pubitemid 38095864)
21. Chukkapalli, V., Oh, S. J. & Ono, A. (2010). Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl Acad. Sci. USA, 107, 1600-1605.
22. Freed, E. O., Orenstein, J. M., Buckler-White, A. J. & Martin, M. A. (1994). Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68, 5311-5320. (Pubitemid 24226606)
23. Ono, A., Huang, M. & Freed, E. O. (1997). Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71, 4409-4418. (Pubitemid 27204130)
24. Hearps, A. C. & Jans, D. A. (2007). Regulating the functions of the HIV-1 matrix protein. AIDS Res. Hum. Retroviruses, 23, 341-346. (Pubitemid 46608553)
25. Wright, M. H., Heal, W. P., Mann, D. J. & Tate, E. W. (2009). Protein myristoylation in health and disease. J. Chem. Biol. 3, 19-35.
26. Ono, A. & Freed, E. O. (1999). Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73, 4136-4144. (Pubitemid 29189859)
27. Spearman, P., Horton, R., Ratner, L. & Kuli-Zade, I. (1997). Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71, 6582-6592. (Pubitemid 27355316)
28. Hermida-Matsumoto, L. & Resh, M. D. (1999). Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J. Virol. 73, 1902-1908. (Pubitemid 29098091)
29. Zhou, W. & Resh, M. D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70, 8540-8548. (Pubitemid 26378433)
30. Sandefur, S., Varthakavi, V. & Spearman, P. (1998). The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. J. Virol. 72, 2723-2732. (Pubitemid 28175507)
31. Saad, J. S., Loeliger, E., Luncsford, P., Liriano, M., Tai, J., Kim, A. et al. (2007). Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J. Mol. Biol. 366, 574-585. (Pubitemid 46136215)
32. Paillart, J. C. & Gottlinger, H. G. (1999). Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J. Virol. 73, 2604-2612. (Pubitemid 29135644)
33. Perez-Caballero, D., Hatziioannou, T., Martin-Serrano, J. & Bieniasz, P. D. (2004). Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J. Virol. 78, 9560-9563. (Pubitemid 39096563)
34. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D. & Summers, M. F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA, 101, 517-522. (Pubitemid 38084668)
35. Dalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D. & Vogt, V. M. (2007). Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81, 6434-6445. (Pubitemid 46878049)
36. Alfadhli, A., Huseby, D., Kapit, E., Colman, D. & Barklis, E. (2007). Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 81, 1472-1478. (Pubitemid 46167868)
37. Dalton, A. K., Murray, P. S., Murray, D. & Vogt, V. M. (2005). Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J. Virol. 79, 6227-6238. (Pubitemid 40617227)
38. Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H. & Summers, M. F. (2006). Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA, 103, 11364-11369. (Pubitemid 44156523)
39. Datta, S. A., Zhao, Z., Clark, P. K., Tarasov, S., Alexandratos, J. N., Campbell, S. J. et al. (2007). Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365, 799-811. (Pubitemid 44960371)
40. Ghanam, R. H., Fernandez, T. F., Fledderman, E. L. & Saad, J. S. (2010). Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. J. Biol. Chem. 285, 41911-41920.
41. Fledderman, E. L., Fujii, K., Ghanam, R. H., Waki, K., Prevelige, P. E., Freed, E. O. & Saad, J. S. (2010). Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH. Biochemistry, 49, 9551-9562.
42. McLaughlin, S. & Aderem, A. (1995). The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20, 272-276.
43. Resh, M. D. (2006). Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2, 584-590. (Pubitemid 44610342)
44. Quinn, P. J. (2002). Plasma membrane phospholipid asymmetry. Subcell. Biochem. 36, 39-60.
45. McLaughlin, S. & Murray, D. (2005). Plasma membrane phosphoinositide organization by protein electrostatics. Nature, 438, 605-611. (Pubitemid 41740564)
46. Lemmon, M. A. (2008). Membrane recognition by phospholipid-binding domains. Nat. Rev., Mol. Cell Biol. 9, 99-111. (Pubitemid 351158910)
47. Leventis, R. & Silvius, J. R. (1998). Lipid-binding characteristics of the polybasic carboxy-terminal sequence of K-ras4B. Biochemistry, 37, 7640-7648. (Pubitemid 28235248)
48. Yagisawa, H., Sakuma, K., Paterson, H. F., Cheung, R., Allen, V., Hirata, H. et al. (1998). Replacements of single basic amino acids in the pleckstrin homology domain of phospholipase C-delta1 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane. J. Biol. Chem. 273, 417-424. (Pubitemid 28042227)
49. Prior, I. A. & Hancock, J. F. (2001). Compartmental-ization of Ras proteins. J. Cell Sci. 114, 1603-1608.
50. Murray, P. S., Li, Z., Wang, J., Tang, C. L., Honig, B. & Murray, D. (2005). Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure (London), 13, 1521-1531. (Pubitemid 41427591)
51. Reil, H., Bukovsky, A. A., Gelderblom, H. R. & Gottlinger, H. G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708. (Pubitemid 28221204)
52. Lee, P. P. & Linial, M. L. (1994). Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J. Virol. 68, 6644-6654.
53. Wang, C. T., Zhang, Y., McDermott, J. & Barklis, E. (1993). Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67, 7067-7076. (Pubitemid 23343832)
54. Wang, C. T., Lai, H. Y. & Li, J. J. (1998). Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J. Virol. 72, 7950-7959.
55. Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W. S. & Ono, A. (2008). Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 82, 2405-2417. (Pubitemid 351293541)
56. Shkriabai, N., Datta, S. A., Zhao, Z., Hess, S., Rein, A. & Kvaratskhelia, M. (2006). Interactions of HIV-1 Gag with assembly cofactors. Biochemistry, 45, 4077-4083.
57. Downes, C. P., Gray, A. & Lucocq, J. M. (2005). Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol. 15, 259-268. (Pubitemid 40603895)
58. Balla, T., Szentpetery, Z. & Kim, Y. J. (2009). Phosphoinositide signaling: new tools and insights. Physiology (Bethesda), 24, 231-244.
59. Di Paolo, G. & De Camilli, P. (2006). Phosphoinosi-tides in cell regulation and membrane dynamics. Nature, 443, 651-657. (Pubitemid 44564702)
60. Campbell, S., Fisher, R. J., Towler, E. M., Fox, S., Issaq, H. J., Wolfe, T. et al. (2001). Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc. Natl Acad. Sci. USA, 98, 10875-10879. (Pubitemid 32878712)
61. Kisseleva, M. V., Wilson, M. P. & Majerus, P. W. (2000). The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. J. Biol. Chem. 275, 20110-20116. (Pubitemid 30441622)
62. Brown, F. D., Rozelle, A. L., Yin, H. L., Balla, T. & Donaldson, J. G. (2001). Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol. 154, 1007-1017. (Pubitemid 34286180)
63. Aikawa, Y. & Martin, T. F. (2003). ARF6 regulates a plasma membrane pool of phosphatidylinositol (4,5)bisphosphate required for regulated exocytosis. J. Cell Biol. 162, 647-659. (Pubitemid 37022942)
64. Alfadhli, A., Barklis, R. L. & Barklis, E. (2009). HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol- (4,5)-bisphosphate. Virology, 387, 466-472.
65. Anraku, K., Fukuda, R., Takamune, N., Misumi, S., Okamoto, Y., Otsuka, M. & Fujita, M. (2010). Highly sensitive analysis of the interaction between HIV-1 Gag and phosphoinositide derivatives based on surface plasmon resonance. Biochemistry, 49, 5109-5116.
66. Alfadhli, A., Still, A. & Barklis, E. (2009). Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J. Virol. 83, 12196-12203.
67. Valentine, K. G., Peterson, R. W., Saad, J. S., Summers, M. F., Xu, X., Ames, J. B. & Wand, A. J. (2010). Reverse micelle encapsulation of membrane-anchored proteins for solution NMR studies. Structure, 18, 9-16.
68. Chan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W. & Wenk, M. R. (2008). Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82, 11228-11238.
69. Monde, K., Chukkapalli, V. & Ono, A. (2011). Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bispho- sphate. J. Virol. 85, 3584-3595.
70. Ehrlich, L. S., Medina, G. N., Khan, M. B., Powell, M. D., Mikoshiba, K. & Carter, C. A. (2010). Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release. J. Virol. 84, 6438-6451.
71. Stansell, E., Apkarian, R., Haubova, S., Diehl, W. E., Tytler, E. M. & Hunter, E. (2007). Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 81, 8977-8988. (Pubitemid 47311441)
72. Saad, J. S., Ablan, S. D., Ghanam, R. H., Kim, A., Andrews, K., Nagashima, K. et al. (2008). Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidy-linositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382, 434-447.
73. Hamard-Peron, E., Juillard, F., Saad, J. S., Roy, C., Roingeard, P., Summers, M. F. et al. (2010). Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J. Virol. 84, 503-515.
74. Chen, K., Bachtiar, I., Piszczek, G., Bouamr, F., Carter, C. & Tjandra, N. (2008). Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry, 47, 1928-1937. (Pubitemid 351287118)
75. Fernandes, F., Chen, K., Ehrlich, L. S., Jin, J., Chen, M. H., Medina, G. N. et al. (2010). Phosphoinositides direct equine infectious anemia virus Gag trafficking and release. Traffic, 12, 438-451.
76. Inlora, J., Chukkapalli, V., Derse, D. & Ono, A. (2011). Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidy- linositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J. Virol. 85, 3802-3810.
77. Purohit, P., Dupont, S., Stevenson, M. & Green, M. R. (2001). Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA, 7, 576-584. (Pubitemid 32416815)
78. Lochrie, M. A., Waugh, S., Pratt, D. G., Jr., Clever, J., Parslow, T. G. & Polisky, B. (1997). In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res. 25, 2902-2910. (Pubitemid 27299809)
79. Chang, C. Y., Chang, Y. F., Wang, S. M., Tseng, Y. T., Huang, K. J. & Wang, C. T. (2008). HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly. Virology, 378, 97-104.
80. Cimarelli, A. & Luban, J. (1999). Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag poly-protein. J. Virol. 73, 5388-5401. (Pubitemid 29274821)
81. Hearps, A. C., Wagstaff, K. M., Piller, S. C. & Jans, D. A. (2008). The N-terminal basic domain of the HIV-1 matrix protein does not contain a conventional nuclear localization sequence but is required for DNA binding and protein self-association. Biochemistry, 47, 2199-2210. (Pubitemid 351287146)
82. Ott, D. E., Coren, L. V. & Gagliardi, T. D. (2005). Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J. Virol. 79, 13839-13847. (Pubitemid 41552682)
83. Ramalingam, D., Duclair, S., Datta, S. A., Ellington, A., Rein, A. & Prasad, V. R. (2011). RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. J. Virol. 85, 305-314.
84. Garbitt, R. A., Albert, J. A., Kessler, M. D. & Parent, L. J. (2001). trans-Acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants. J. Virol. 75, 260-268.
85. Parent, L. J., Cairns, T. M., Albert, J. A., Wilson, C. B., Wills, J. W. & Craven, R. C. (2000). RNA dimerization defect in a Rous sarcoma virus matrix mutant. J. Virol. 74, 164-172. (Pubitemid 30002895)
86. Wang, H., Norris, K. M. & Mansky, L. M. (2003). Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. J. Virol. 77, 9431-9438. (Pubitemid 37011039)
87. Gudleski, N., Flanagan, J. M., Ryan, E. P., Bewley, M. C. & Parent, L. J. (2010). Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyo-pherins and viral RNA. Proc. Natl Acad. Sci. USA, 107, 9358-9363.
88. Mariani, R., Rutter, G., Harris, M. E., Hope, T. J., Krausslich, H. G. & Landau, N. R. (2000). A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74, 3859-3870. (Pubitemid 30180328)
89. Bieniasz, P. D. & Cullen, B. R. (2000). Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74, 9868-9877.
90. Reed, M., Mariani, R., Sheppard, L., Pekrun, K., Landau, N. R. & Soong, N. W. (2002). Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J. Virol. 76, 436-443. (Pubitemid 33139031)
91. Chen, B. K., Rousso, I., Shim, S. & Kim, P. S. (2001). Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells. Proc. Natl Acad. Sci. USA, 98, 15239-15244. (Pubitemid 34013998)
92. Kiernan, R. E., Ono, A., Englund, G. & Freed, E. O. (1998). Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72, 4116-4126. (Pubitemid 28188717)
93. Sherer, N. M., Swanson, C. M., Papaioannou, S. & Malim, M. H. (2009). Matrix mediates the functional link between HIV-1 RNA nuclear export elements and Gag assembly competency in murine cells. J. Virol. 83, 8525-8535.
94. Jin, J., Sturgeon, T., Weisz, O. A., Mothes, W. & Montelaro, R. C. (2009). HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. PLoS One, 4, e6551.
95. Lindwasser, O. W. & Resh, M. D. (2002). Myristoyla-tion as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl Acad. Sci. USA, 99, 13037-13042.
96. Ono, A. & Freed, E. O. (2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA, 98, 13925-13930. (Pubitemid 33116000)
97. Pickl, W. F., Pimentel-Muinos, F. X. & Seed, B. (2001). Lipid rafts and pseudotyping. J. Virol. 75, 7175-7183. (Pubitemid 32641605)
98. Ono, A., Waheed, A. A. & Freed, E. O. (2007). Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology, 360, 27-35.
99. Liao, Z., Graham, D. R. & Hildreth, J. E. (2003). Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res. Hum. Retroviruses, 19, 675-687. (Pubitemid 37047093)
100. Ono, A. (2010). Relationships between plasma membrane microdomains and HIV-1 assembly. Biol. Cell, 102, 335-350.
101. Waheed, A. A. & Freed, E. O. (2009). Lipids and membrane microdomains in HIV-1 replication. Virus Res. 143, 162-176.
102. Datta, S. A., Curtis, J. E., Ratcliff, W., Clark, P. K., Crist, R. M., Lebowitz, J. et al. (2007). Conformation of the HIV-1 Gag protein in solution. J. Mol. Biol. 365, 812-824. (Pubitemid 44960372)
103. Datta, S. A., Heinrich, F., Raghunandan, S., Krueger, S., Curtis, J. E., Rein, A. & Nanda, H. (2010). HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J. Mol. Biol. 406, 205-214.
104. Jones, C. P., Datta, S. A., Rein, A., Rouzina, I. & Musier-Forsyth, K. (2010). Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J. Virol. 85, 1594-1603.
105. Llewellyn, G. N., Hogue, I. B., Grover, J. R. & Ono, A. (2010). Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 6, e1001167.
106. Chen, P., Hubner, W., Spinelli, M. A. & Chen, B. K. (2007). Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81, 12582-12595. (Pubitemid 350085872)
107. Jolly, C., Kashefi, K., Hollinshead, M. & Sattentau, Q. J. (2004). HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199, 283-293. (Pubitemid 38129707)
108. Igakura, T., Stinchcombe, J. C., Goon, P. K., Taylor, G. P., Weber, J. N., Griffiths, G. M. et al. (2003). Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science, 299, 1713-1716. (Pubitemid 36337193)
109. Hubner, W., McNerney, G. P., Chen, P., Dale, B. M., Gordon, R. E., Chuang, F. Y. et al. (2009). Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science, 323, 1743-1747.
110. Rudnicka, D., Feldmann, J., Porrot, F., Wietgrefe, S., Guadagnini, S., Prevost, M. C. et al. (2009). Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83, 6234-6246.
111. Sattentau, Q. (2008). Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev., Microbiol. 6, 815-826.
112. Feldmann, J. & Schwartz, O. (2010). HIV-1 virolog-ical synapse: live imaging of transmission. Viruses, 2, 1666-1680.
113. Jolly, C. (2010). T cell polarization at the virological synapse. Viruses, 2, 1261-1278.
114. Sattentau, Q. J. (2010). Cell-to-cell spread of retrovi-ruses. Viruses, 2, 1306-1321.
115. Mothes, W., Sherer, N. M., Jin, J. & Zhong, P. (2010). Virus cell-to-cell transmission. J. Virol. 84, 8360-8368.
116. Bryant, M. L., Heuckeroth, R. O., Kimata, J. T., Ratner, L. & Gordon, J. I. (1989). Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc. Natl Acad. Sci. USA, 86, 8655-8659. (Pubitemid 20010282)
117. Bryant, M. L., Ratner, L., Duronio, R. J., Kishore, N. S., Devadas, B., Adams, S. P. & Gordon, J. I. (1991). Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus productionin achronically infected human lymphoid cell line. Proc. Natl Acad. Sci. USA, 88, 2055-2059. (Pubitemid 21916352)
118. Morikawa, Y., Hinata, S., Tomoda, H., Goto, T., Nakai, M., Aizawa, C. et al. (1996). Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J. Biol. Chem. 271, 2868-2873. (Pubitemid 26047910)
119. Furuishi, K., Matsuoka, H., Takama, M., Takahashi, I., Misumi, S. & Shoji, S. (1997). Blockage of N-myristoylation of HIV-1 gag induces the production of impotent progeny virus. Biochem. Biophys. Res. Commun. 237, 504-511. (Pubitemid 27434714)
120. Bunka, D. H., Platonova, O. & Stockley, P. G. (2010). Development of aptamer therapeutics. Curr. Opin. Pharmacol. 10, 557-562.